SCHEMBL23093030

SCHEMBL23093030

Cc1cc(C#CCO)ccc1NC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MMP2 P08253 1/20 0.42
MMP12 P39900 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
TP53 P04637 2/20 0.38
MELK Q14680 1/20 0.38
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GFER P55789 1/20 0.37
GRIK1 P39086 1/20 0.36
GRIA2 P42262 1/20 0.36
GRIK2 Q13002 1/20 0.36
GRIK3 Q13003 1/20 0.36
GRIK5 Q16478 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81322 0.76 MELK (0.46) MMP2MMP12ALDH1A1HTTMELK
SCHEMBL17733479 0.73 MELK (0.41) MMP2MMP12ALDH1A1MELKGRIK1
SCHEMBL1310828 0.72 GABRP (0.36) MEN1KMT2ACYP1A2
SCHEMBL81541 0.71 MELK (0.42) KMT2AMMP2MMP12SMN1; SMN2ALDH1A1
SCHEMBL13531864 0.71 MELK (0.42) KMT2AMMP2MMP12SMN1; SMN2ALDH1A1
SCHEMBL15099419 0.70 CTDSP1 (0.42) MMP2MMP12SMN1; SMN2MELKL3MBTL1
SCHEMBL8048607 0.70 SLC1A3 (0.53) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL2091371 0.70 MEN1 (0.71) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL11118946 0.69 GPR174 (0.59) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL8105989 0.69 MELK (0.44) MMP2MMP12ALDH1A1MELKGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021050547-A1 MITOCHONDRIAL COMPLEX I INHIBITORS AND METHODS OF USE Sanford Burnham Prebys Medical Discovery Institute (US) 2021-03-18 WO disclosed